Chlorampiocell is used in the treatment of chronic lymphocytic leukemia, non-Hodgkin's lymphoma, Hodgkin's disease, ovarian cancer, the presence of globular globulin and Aldenstrom (first). Adverse effects, except for osteoporosis, are not common.
However, a widespread, diffuse rash can develop and develop into Stevens Johnson Syndrome or the toxic epidermal parenchyma. If a rash occurs, the following treatment is inhibited by chlorampiocell.
However, a widespread, diffuse rash can develop and develop into Stevens Johnson Syndrome or the toxic epidermal parenchyma. If a rash occurs, the following treatment is inhibited by chlorampiocell.
